ReviewPharmaceuticals (Basel, Switzerland)2010

Thrombospondin-1 as a Paradigm for the Development of Antiangiogenic Agents Endowed with Multiple Mechanisms of Action.

Marco Rusnati et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.